Graphene brain sensor tested in humans for first time

NCT ID NCT06368310

Completed Knowledge-focused Sponsor: University of Manchester Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 01, 2026 · Updated 4 times

Summary

This study tests a new graphene-based electrode array used during brain tumor surgery to map brain activity. Ten participants will have the device used alongside standard monitoring to check its safety and how well it records brain signals. If awake during surgery, they may do simple tasks to help decode brain signals. The goal is to see if this technology is safe and effective for future use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Graphene Cortical Interface (device)
What this could lead to: If successful, this could pave the way for safer, higher-quality brain mapping during surgery, potentially improving outcomes for brain tumor patients.
What could go wrong: This is a very early, small trial (10 people) focused on safety, not treatment. The device may not work as hoped, and risks include surgical complications or poor signal quality.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN TUMOR GLIOMA

Contacts and locations

Locations

Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust

Salford, Greater Manchester, M6 8HD, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.